Sandra Levy
ARTICLES BY THIS AUTHOR
- 4/20/2021
Hikma resumes launch of generic Advair Diskus
Hikma will immediately resume launch activities of generic Advair Diskus in 100 mcg/50 mcg and 250 mcg/50 mcg dosage strengths. - 4/20/2021
CVS Health declares 2021 the ‘Year of the Pharmacist’ in health trends report
CVS Health calls 2021 "Year of the Pharmacist," as pharmacists expanded their clinical role amid the pandemic, in its annual Health Trends Report, which sizes up some of the biggest factors influencing health care this year. - 4/19/2021
Bayer promotes 2 pharma execs
Nelson Ambrogio and John Berrios will serve on Bayer's U.S. pharmaceutical leadership team and report directly to Sebastian Guth, Bayer’s president of pharmaceuticals, Americas region. - 4/19/2021
Legislation on generics, biosimilars headed to Biden's desk
The two pieces of legislation — one focusing on generics, another on biosimilars — are aimed at lowering healthcare costs for consumers. - 4/19/2021
Camber offers generic Sabril
Camber's generic Sabril is used in combination with other medications to treat seizure disorders. - 4/19/2021
NACDS 2021 Annual Meeting Business Program III to feature Merlo among speakers
CVS Health’s Larry Merlo, Morgan Stanley’s Carla Harris, and presidential advisor Cedric Richmond will take the virtual stage at NACDS' 2021 Annual Meeting Business Program III. - 4/19/2021
State of the Pharmacy 2021: Executives weigh in
Executives from leading pharmaceutical and technology and automation companies size up the pharmacy space as we move into the second year of the pandemic and pharmacies continue to play a crucial role in COVID-19 vaccinations. - 4/19/2021
Fresenius Kabi taps Sandoz’s Pawlu to head generics, complex formulations
Fresenius Kabi has tapped former Sandoz executive Christian Pawlu to lead generics and complex unit formulations. - 4/18/2021
Kinney Drugs partners with law enforcement for National DEA Prescription Drug Take-Back Day
Kinney Drugs will host several events at its New York and Vermont stores on Saturday, April 24th from 10 a.m. to 2 p.m. - 4/18/2021
FDA approves new indication for ALK's Ragwitek
Ragwitek now is indicated to treat ragweed pollen allergy in children and adolescents 5-17 years old, in addition to adults as old as 65.
